Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Alsoud D, Moes DJAR, Wang Z, Soenen R, Layegh Z, Barclay M, Mizuno T, Minichmayr IK, Keizer RJ, Wicha SG, Wolbink G, Lambert J, Vermeire S, de Vries A, Papamichael K, Padullés-Zamora N, Dreesen E. Alsoud D, et al. Among authors: padulles zamora n. Ther Drug Monit. 2024 Jun 1;46(3):291-308. doi: 10.1097/FTD.0000000000001204. Epub 2024 Apr 17. Ther Drug Monit. 2024. PMID: 38648666 Review.
Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy.
Santacana Juncosa E, Rodríguez-Alonso L, Padullés Zamora A, Guardiola J, Rodríguez-Moranta F, Serra Nilsson K, Bas Minguet J, Morandeira Rego F, Colom Codina H, Padullés Zamora N. Santacana Juncosa E, et al. Among authors: padulles zamora n. Br J Clin Pharmacol. 2021 Feb;87(2):494-505. doi: 10.1111/bcp.14410. Epub 2020 Jun 26. Br J Clin Pharmacol. 2021. PMID: 32495380 Free article.
[Individualized infliximab therapy: pharmacokinetic monitoring].
Santacana-Juncosa E, Padullés-Zamora A, Colom Codina H, Rodríguez-Alonso L, Guardiola-Capon J, Padullés-Zamora N. Santacana-Juncosa E, et al. Among authors: padulles zamora n. Farm Hosp. 2015 Jan 1;39(1):59-60. doi: 10.7399/fh.2015.39.1.7791. Farm Hosp. 2015. PMID: 25680435 Free article. Spanish. No abstract available.
Disease-modifying treatments for patients with multiple sclerosis in Spain.
Pérez AS, Casado SE, Álvarez Payero M, Escolano Pueyo ÁE, Arévalo Bernabé ÁG, Padullés Zamora N, Diaz Ruiz P, López González AM. Pérez AS, et al. Among authors: padulles zamora n. Farm Hosp. 2023 Jul-Aug;47(4):155-160. doi: 10.1016/j.farma.2023.03.009. Epub 2023 May 2. Farm Hosp. 2023. PMID: 37142541 Free article. English, Spanish.
PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.
Milara J, Outeda-Macias M, Aumente-Rubio MD, Más-Serrano P, Aldaz A, Calvo MV, García-Simón MS, Martin-Barbero M, Padullés-Zamora N, Schoenenberger JA, Saavedra-Aldrich M, Tévar-Alfonso E, Saval A, Pastor-Clerigues A, García M, Margusino-Framiñan L, Montero-Alvarez JL, Merino E, Herrero JI, Beunza M, Conesa-Zamora P, Gimenez-Manzorro A, Comas-Sugrañes D, Cano-Marron M, Jiménez-Mutiloa E, Díaz-Ruíz P, Cortijo J. Milara J, et al. Among authors: padulles zamora n. Farm Hosp. 2015 Jan 1;39(1):29-43. doi: 10.7399/fh.2015.39.1.8547. Farm Hosp. 2015. PMID: 25680433
Is there a difficulty in maintaining haemoglobin target levels in pre-dialysis patients treated with erythropoiesis-stimulating agents?
Santacana-Juncosa E, Padullés-Zamora N, Padullés-Zamora A, Comas-Sugrañes D, Santulario-Verdú L, Sanmartí-Martínez N, Martínez-Castelao A. Santacana-Juncosa E, et al. Among authors: padulles zamora n. Nefrologia. 2014;34(2):263-4. doi: 10.3265/Nefrologia.pre2013.Dec.12312. Nefrologia. 2014. PMID: 24658202 Free article. English, Spanish. No abstract available.
18 results